Key Highlights

  • Hawkins (NASDAQ:HWKN) reported fiscal second-quarter 2027 diluted EPS of USD 1.34 on October 26, 2026, up from USD 1.08 and above consensus of USD 1.18 in published market data.
  • Sales rose 12% to USD 313.8 million, with organic growth of 11% and about USD 3.7 million from acquisitions, while net income rose 23% to USD 27.8 million.
  • Water Treatment sales rose 16% to USD 175.0 million and gross profit in that segment rose 20%, while Industrial Solutions rose 10% and Food and Health Sciences rose 5%.
  • Adjusted EBITDA rose 16% to USD 59.1 million, and trailing twelve-month adjusted EBITDA reached USD 188.0 million as the company closed two water distributor acquisitions.

Where the Beat Came From

Hawkins distributes and blends chemicals for water treatment, industrial customers and food and health sciences. In the quarter ended September 27, 2026, sales were USD 313.8 million, up from USD 280.4 million. Water Treatment, its largest segment, grew 16% to USD 175.0 million. Industrial Solutions rose 10% to USD 62.2 million, and Food and Health Sciences rose 5% to USD 76.7 million. Gross profit rose 13% to USD 76.6 million, about 24% of sales, and operating income rose to USD 41.9 million from USD 33.9 million. Net income of USD 27.8 million equals USD 1.34 per diluted share, up 24% on EPS, simple arithmetic on two reported figures. Adjusted EBITDA of USD 59.1 million was 16% higher, so profit grew faster than sales, which signals operating leverage in the quarter.

Acquisitions and Strategy

Dave Symonds and Associates, a Florida water distributor focused on blended phosphates, closed during the quarter, and Eagle Labs, a Dallas-Fort Worth water treatment distributor with two locations and in-house manufacturing, closed after quarter end. CEO Patrick Hawkins said results reflect the agility of employees and the resilience of the business model, and said Hawkins (NASDAQ:HWKN) will keep investing in higher-margin businesses and acquiring accretive companies. Water Treatment gross profit growth of 20% outpaced sales growth of 16%, which points to margin gains in the mix. Acquisitions contributed only about USD 3.7 million of sales this quarter, so organic demand did most of the work. The company has used acquisitions to add distribution points and local manufacturing capability in water treatment, a business with recurring demand from municipal and industrial users.

Outlook and Risks

Management expects second-half trends to resemble the first half. One headwind is explicit: second-half fiscal 2027 SG&A will not benefit from the USD 6.2 million non-recurring reduction that helped the second half of fiscal 2026, so earnings growth may be slower. Other risks include chemical input prices, customer concentration in municipal water, and the cost and integration of further deals. The release gave no numeric guidance. Investors in Hawkins (NASDAQ:HWKN) will watch Water Treatment growth, gross margin and the effect of the new acquisitions. A trailing adjusted EBITDA of USD 188.0 million gives the company capacity to keep buying distributors. Slower growth in Food and Health Sciences at 5% is another point to monitor, since it trails the larger water business.

Where Things Stand

The answer is that Hawkins beat because Water Treatment grew 16% and its gross profit grew 20%, lifting EPS to USD 1.34 against consensus of USD 1.18. Organic growth was 11%, so acquisitions were a small part of the story. Management expects the second half to look like the first, but a USD 6.2 million SG&A benefit from last year will not repeat. Hawkins (NASDAQ:HWKN) keeps buying water distributors. The next catalyst is fiscal third-quarter results. This is not investment advice.